Federal contract award
75F40123C00138
QUANTIFYING PATIENT PRIORITIES FOR CLINICAL EVIDENCE ON THE IMPACT OF OSSEOINTEGRATED LIMB PROSTHESES
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $748.9K |
| Current contract value | $748.9K |
| Potential contract value / ceiling | $1.2M |
| Start date | Sep 5, 2023 |
| Current end date | Sep 28, 2026 |
| Potential end date | Sep 28, 2026 |
| Latest award activity | May 19, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 19, 2026 | P00003 | $0 | THE PURPOSE OF THIS NO COST MODIFICATION IS TO CORRECT THE PERIOD OF PERFORMANCE AND CONTRACT DELIVERABLES. |
| May 13, 2024 | P00002 | $0 | THE PURPOSE OF THIS NO COST MODIFICATION IS TO CORRECT THE PERIOD OF PERFORMANCE AND CONTRACT DELIVERABLES. |
| Sep 29, 2023 | P00001 | $457.7K | QUANTIFYING PATIENT PRIORITIES FOR CLINICAL EVIDENCE ON THE IMPACT OF OSSEOINTEGRATED LIMB PROSTHESES |
| Sep 5, 2023 | 0 | $291.2K | QUANTIFYING PATIENT PRIORITIES FOR CLINICAL EVIDENCE ON THE IMPACT OF OSSEOINTEGRATED LIMB PROSTHESES |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| Ian Weiss | Contact | Ian.Weiss@fda.hhs.gov (301) 796-5728 | Source | May 18, 2023 |
| Ravi Chandan Palaniandy | Contact | RaviChandan.Palaniandy@fda.hhs.gov 301-796-4378 | Source | May 18, 2023 |
| Ian Weiss | Contact | Ian.Weiss@fda.hhs.gov (301) 796-5728 | Source | Jan 17, 2023 |
| Ravi Chandan Palaniandy | Contact | RaviChandan.Palaniandy@fda.hhs.gov 301-796-4378 | Source | Jan 17, 2023 |
| Ian Weiss | Contact | Ian.Weiss@fda.hhs.gov (301) 796-5728 | Source | Jan 9, 2023 |
| Ravi Chandan Palaniandy | Contact | RaviChandan.Palaniandy@fda.hhs.gov 301-796-4378 | Source | Jan 9, 2023 |
| Ian Weiss | Contact | Ian.Weiss@fda.hhs.gov (301) 796-5728 | Source | Jan 9, 2023 |
| Ravi Chandan Palaniandy | Contact | RaviChandan.Palaniandy@fda.hhs.gov 301-796-4378 | Source | Jan 9, 2023 |
| Ian Weiss | Contact | Ian.Weiss@fda.hhs.gov (301) 796-5728 | Source | Jan 4, 2023 |
| Ravi Chandan Palaniandy | Contact | RaviChandan.Palaniandy@fda.hhs.gov 301-796-4378 | Source | Jan 4, 2023 |
| Ian Weiss | Contact | Ian.Weiss@fda.hhs.gov (301) 796-5728 | Source | Jan 4, 2023 |
| Ravi Chandan Palaniandy | Contact | RaviChandan.Palaniandy@fda.hhs.gov 301-796-4378 | Source | Jan 4, 2023 |
| Ian Weiss | Contact | Ian.Weiss@fda.hhs.gov (301) 796-5728 | Source | Jan 3, 2023 |
| Ravi Chandan Palaniandy | Contact | RaviChandan.Palaniandy@fda.hhs.gov 301-796-4378 | Source | Jan 3, 2023 |
| Ian Weiss | Contact | Ian.Weiss@fda.hhs.gov (301) 796-5728 | Source | Nov 17, 2022 |
| Ravi Chandan Palaniandy | Contact | RaviChandan.Palaniandy@fda.hhs.gov 301-796-4378 | Source | Nov 17, 2022 |
| Ian Weiss | Contact | Ian.Weiss@fda.hhs.gov (301) 796-5728 | Source | Nov 14, 2022 |
| Ravi Chandan Palaniandy | Contact | RaviChandan.Palaniandy@fda.hhs.gov 301-796-4378 | Source | Nov 14, 2022 |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.